20(S)-Protopanaxadiol Inhibition of Progression and Growth of Castration-Resistant Prostate Cancer

Castration-resistant progression of prostate cancer after androgen deprivation therapies remains the most critical challenge in the clinical management of prostate cancer. Resurgent androgen receptor (AR) activity is an established driver of castration-resistant progression, and upregulation of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Bo, Qi, Yanfeng, Yang, Yan, Liu, Xichun, Xu, Duo, Guo, Wei, Zhan, Yang, Xiong, Zhenggang, Zhang, Allen, Wang, Alun R., Fu, Xueqi, Zhang, Haitao, Zhao, Lijing, Gu, Jingkai, Dong, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222907/
https://www.ncbi.nlm.nih.gov/pubmed/25375370
http://dx.doi.org/10.1371/journal.pone.0111201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222907/
https://www.ncbi.nlm.nih.gov/pubmed/25375370
http://dx.doi.org/10.1371/journal.pone.0111201

Ejemplares similares